
    
      The objectives of this clinical trial are to compare the efficacy of twice-daily topical LEO
      124249 30 mg/g ointment with LEO 124249 ointment vehicle for 12 weeks in the treatment of
      hair loss in subjects with alopecia areata, to evaluate the safety of this treatment, to
      evaluate hair regrowth, to determine subject quality of life, and to explore disease
      mechanism and its biomarkers.
    
  